+ T-cell activation, characterized by increased CD28 expression, reduces neointima formation after arterial injury in mice. The CD8 + CD28 hi phenotype is associated with increased effector function. In this study, we used a mouse model that has CD8 + but no CD4 + T cells (CD4À/À) to assess the role of CD8 + T cells and test the function of CD8 + CD28 hi T cells in modulating neointima formation after arterial injury.
Background--CD8
+ T-cell activation, characterized by increased CD28 expression, reduces neointima formation after arterial injury in mice. The CD8 + CD28 hi phenotype is associated with increased effector function. In this study, we used a mouse model that has CD8 + but no CD4 + T cells (CD4À/À) to assess the role of CD8 + T cells and test the function of CD8 + CD28 hi T cells in modulating neointima formation after arterial injury.
Methods and Results--Neointima formation after pericarotid arterial cuff injury was significantly less in CD4À/À mice compared with wild-type (WT) mice. Negligible baseline lytic activity by splenic CD8 + T cells from uninjured WT mice against target syngeneic smooth muscle cells was significantly increased 7 days after injury. Interestingly, CD8 + T cells from uninjured CD4À/À mice had significant lytic activity at baseline that remained elevated 7 days after injury. CD8
+ T-cell lytic activity was significantly reduced by depletion of CD28 hi cells. CD8 + CD28 hi T cells adoptively transferred into recipient Rag-1À/À mice significantly reduced neointima formation compared with CD8 + CD28 + T-cell recipient mice. T -cell activation plays an important role in neointima formation in response to arterial injury. [1] [2] [3] [4] [5] [6] [7] We recently reported that both CD4 + and CD8 + T cells were activated after arterial injury, as evidenced by increased CD44 expression on both types of T cells. However, subsequent adoptive transfer experiments indicated that only CD8 + T cells modulated neointima formation. This was associated with increased CD28 expression in CD8 + T cells, but not in CD4 + T cells. 8 Under basal conditions, CD28 is expressed by mouse CD8 + T cells (CD8 + CD28 + ), but is upregulated in a subpopulation on activation (CD8 + CD28 hi ). 9 Effector functions after activation have been associated with the CD28 hi phenotype. 10, 11 In addition, mouse memory CD8 + T cells are subdivided based on CD28 expression into CD28 + and CD28 hi . 12 Thus, we selected CD28 hi as the phenotype marker for further study of CD8 + T cells in the response to arterial injury.
Conclusions--CD8
CD4 and CD8 T cells contain heterogeneous subpopulations. Specific T-cell response to arterial injury remains unclear given the lack of understanding of the role of various T-cell subtypes, highlighted by very few studies on CD8 + T cells. In the current report, we investigated the role of CD8 + T cells in neointima formation using a mouse model that has CD8 + but no CD4 + T cells (CD4À/À mice) and compared it with that of wild-type (WT) mice. This CD4À/À mouse model enabled us to assess the role of CD8 + T cells in the absence of helper T cells in the response to arterial injury. 8 The role of CD8 + T cells was further evaluated by testing the function of the CD28 hi subpopulation in neointima formation.
Our results confirm the previous report on the role of CD8 + T cells in reducing neointima formation 8 and extend it by identifying the CD8 + CD28 hi as the specific subpopulation involved in this process.
Methods

Arterial Injury
Mice were housed in a pathogen-free facility with access to food and water ad libitum. Aseptic periadventitial cuff injury was performed on the right carotid artery of 25-week-old male WT, CD4À/À, or Rag-1À/À mice on a C57Bl6/J background (Jackson Laboratory), as previously described. 7, 8, 13, 14 Briefly, mice were anesthetized with ketamine and xylazine, and carprofen was administered prior to surgery for postsurgical pain relief. The right carotid artery was dissected and exposed, a 2.5-mm-long Tygon tube (internal diameter of 0.51 mm) with a longitudinal opening was placed around the right carotid artery and secured with ligatures around it, and the wound was closed with sutures. Carotid arteries were harvested after perfusion with normal saline for 10 minutes. The Cedars-Sinai Institutional Animal Care and Use Committee approved the experimental protocols specifically used in this study.
Morphometric Analysis
Frozen sections 6 to 8 lm thick were collected from the injured carotid arteries and stained with hematoxylin and eosin or Verhoeff Elastic Van Geison (Sigma), and the vessel area was measured as described previously using image analysis software (ImagePro). 15 
Flow Cytometry
At different times after injury, mice were euthanized, and the regional lymph nodes and spleens were collected and subjected to red blood cell lysis. Cells were then stained with CD8b and CD44, CD25, or CD28 (BD Bioscience). Mouse aortic smooth muscle cells (SMCs) grown in DMEM/F12 medium supplemented with 10% FBS were trypsinized and stained with monoclonal antibodies to B7-1 and B7-2 (eBioscience). Matching IgG isotypes were used as control. Cells were analyzed on a BD LSR-II apparatus (BD Bioscience).
T-Cell Enrichment and Transfer
Spleen cells from age-matched donor CD4À/À mice were pooled. The cells were then negatively selected for CD8 + T cells using a commercially available kit (Invitrogen) with paramagnetic beads and a magnetic particle concentrator, 7, 8 as recommended by the manufacturer (Dynal 
Immunohistochemistry
Frozen sections 6 to 8 lm thick were fixed in ice-cold acetone and stained for active caspase-3 or CD8b (BD Biosciences). Biotin-conjugated secondary antibody was used for detection and visualized using horseradish peroxidase-conjugated streptavidin and AEC (DAKO). Omission of the primary antibody was used as a negative control.
SMC Lytic Assay
The CD8 + cytolytic assay was performed as previously described. 8 
Reverse-Transcription PCR
Individual spleens were collected and TRIzol (Invitrogen) was used to extract RNA. Real-time polymerase chain reaction (PCR) to assess IL-2 expression with ubiquitin as a reference was performed using the delta-delta Ct method. For isolated CD8 + T cells, aliquots were taken prior to performing lytic assays and pooled, or the culture medium after lytic assays was pooled and collected according to groups and centrifuged to pellet CD8 + T cells. RNA was extracted, and real-time PCR was used to assess cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression with ubiquitin as a reference using the delta-delta Ct method. Carotid arteries were pooled from 4 to 5 mice, the RNA extracted, subjected to reverse transcription using Superscript II (Invitrogen), and PCR performed using B7-1significance for multiple groups followed by the NewmanKeuls post test for comparison. Significance was set at P<0.05.
Results
Characterization of CD8 + T Cells in CD4À/À Mice After Arterial Injury
Arterial injury in WT mice results in T-cell activation characterized by increased CD28 expression on CD8 + T cells that have the propensity to reduce neointima formation. 8 Thus, we characterized CD8 + T-cell response to injury in mice that have (Table 1) . Thus, the profile observed in the injured CD4À/À mice did not correspond with that observed in injured WT mice. 8 Neointima formation after injury was then compared between WT and CD4À/À mice.
Reduced Neointima Formation in CD4À/À Mice Compared With WT Mice
Twenty-one days after arterial injury there was significantly reduced neointima formation in CD4À/À mice compared with WT mice (0.005AE0.004 mm 2 , n=11 versus 0.012AE0.008 mm 2 , n=12, respectively; P=0.01; Figure 2A through 2E); whereas no difference was observed in the medial area. Hence, intima-to-media ratio (I/M) was significantly reduced in CD4À/À mice compared with WT mice (0.14AE0.03 versus 0.30AE0.04, respectively; P=0.007; Figure 2F ). This reduced neointima formation in CD4À/À mice was associated with significantly increased active caspase-3 immunoreactivity in the injured arteries of CD4À/À mice compared with WT mice ( Figure 2G through 2I) , suggesting increased SMC death in CD4À/À mice.
Cytolytic Activity of CD8 + T Cells From WT and CD4À/À Mice
Given the increased active caspase-3 immunoreactivity in the injured arteries of CD4À/À mice, we hypothesized that vascular smooth muscle cells are targets of activated CD8 + T cells after injury. The cytolytic activity of CD8 + T cells from spleens of CD4À/À and WT mice against syngeneic aortic SMCs as target cells was therefore assessed at the different points after injury. SMC lysis by CD8 + T cells from uninjured WT mice was negligible ( Figure 3A ). There was a significant increase in SMC lysis by CD8 + T cells from 7-day injured mice, which persisted to a lesser degree in 21-day injured mice. In contrast, CD8 + T cells from uninjured CD4À/À mice ( Figure 3B ) already had significant lytic activity at baseline, which further increased slightly 7 days after injury and significantly decreased at day 21.
CD4À/À Mice Have Increased IL-2 Expression in the Steady State
Cytolytic activity of CD8 + T cells is enhanced by IL-2.
20,21
Hence, we hypothesized that the higher lytic activity of CD8 + T cells from uninjured CD4À/À mice compared with WT mice is a result of higher splenic steady-state IL-2 expression in CD4À/À mice. Splenic IL-2 mRNA expression was therefore assessed between uninjured WT and CD4À/À mice in the steady state. There was significantly higher IL-2 expression in the CD4À/À mice (n=4) compared with WT mice (n=7; 2.1AE0.8 versus 0.9AE0.5 fold-change, respectively; P=0.01).
CD8 + CD28 hi T Cells Have Lytic Function
The increased lytic activity in CD8 + T cells from 7-day injured WT mice parallels our previously reported increase in CD28 expression 7 days after injury. 8 Figure 3C , left). Because lytic activity was already high in uninjured CD4À/À mice, CD28
hi depletion was also performed with CD8 + T cells pooled from uninjured CD4À/À mice and the cells tested for lytic activity. Depletion of CD28 hi cells from the CD8 + T cells pooled from uninjured CD4À/À mice significantly reduced cytolytic activity against SMCs (Figure 3C, middle) . Flow-cytometric analysis confirmed the depletion of CD28 hi cells ( Figure 3C , right).
Increased Lytic Activity Coincides With Increased CTLA-4 Expression
To determine if the opposing signaling molecule was also present in CD8 + T cells that had increased cytolytic activity, we assessed CTLA-4 mRNA expression from CD8 + T cells pooled from spleens of uninjured WT or CD4À/À mice aliquoted prior to the lytic assays. There was higher CTLA-4 expression observed in the CD8 + T cells from CD4À/À mice ( Figure 3D ). CTLA-4 expression was then assessed in the total CD8 + T-cell pool from CD4À/À mice before and after the cytolytic assay. Culture medium was collected after several lytic assays and centrifuged to pellet the CD8 + T cells. Cell pellets were then pooled to assay for CTLA-4 mRNA expression. There was a nearly 2-fold increase in CTLA-4 expression in total CD8 + T cells after the cytolytic assay. This occurred primarily in the CD28 hi population because CD8 + T cells depleted of CD28 hi cells did not have increased CTLA-4 mRNA expression ( Figure 3E ).
Arterial SMCs Express the CD28 Ligand B7-1
Expression of the CD28 ligand B7-1 (CD80) increases susceptibility of syngeneic target cells to CD8 + T-cell lysis.
22 Figure 1 . Characterization of CD8 + T-cell response to arterial injury in CD4À/À mice. Representative scatter plots of activation markers CD44, CD25, and CD28 assessed in lymph node (top row) and spleen (second, third, and bottom rows) in uninjured mice (UI, left column) or 7 and 21 days after injury (D7 and D21, middle and right columns, respectively). The CD8b + (FITC) gate was used for cell analysis. CD44, CD25, and CD28 antibodies were PE conjugated. FITC indicates fluorescein isothiocyanate; PE, phycoerythrin.
Hence, cultured WT SMCs were checked for expression of known CD28 ligands B7-1 and B7-2 (CD86) using flow cytometry and assessed using mean fluorescence intensity (MFI). Significant B7-1 expression was detected on cultured SMCs (MFI=518.7AE6.2, n=3; Figure 4A , top), but B7-2 was only minimally expressed (MFI=11.5AE0.2, n=3; Figure 4A , bottom). To confirm the in vivo relevance of the finding, carotid arteries from 4 to 5 WT mice were pooled and assessed for B7-1 mRNA expression after injury at different times. Minimal B7-1 mRNA was present in uninjured arteries, but increased within a day after injury and peaked 7 days after injury. Low expression of B7-1 was still detectable 21 days after injury ( Figure 4B ). Figure 6D ).
CD8
Discussion
In the current study, we have not only confirmed our previous observation that CD8 + T cells reduce neointima formation after arterial injury by testing it in a different model (CD4À/À mice), but also provided the following novel findings: (1 Hence, the kinetics of lytic activity of splenic CD8 + T cells was assessed after arterial injury. In WT mice, we observed increased CD8 + T-cell cytolytic activity 7 days after arterial injury, which persisted to a lesser degree up to 21 days after injury.
Significantly reduced neointima formation in the CD4À/À mice predicted that cytolytic activity would be higher in the CD8 + T cells from these mice if, as we hypothesized, CD8 + T-cell-mediated cytolytic activity was involved in controlling the neointima. Indeed, the profile observed in the CD8 + T cells from the CD4À/À mouse spleens differed dramatically from WT mice in that even before arterial injury, there was already significant lytic activity against syngeneic SMCs. The presence of significant lytic activity in the steady (uninjured) state of CD4À/À mice prompted us to assess differences in the immune profile compared with WT mice. IL-2 is a known regulator of T-cell function. Relevantly to our studies, exogenous IL-2 enhanced CD8 + cytolytic activity. 20, 21 Thus, increased splenic IL-2 mRNA expression in the steady state of CD4À/À mice compared with WT mice is in agreement with the reported role of IL-2 bioavailability in enhancing cytolytic activity.
The results from the injury time course of cytolytic activity of CD8 + T cells from WT mice paralleled the increased CD28 expression on WT CD8 + T cells after injury that we previously reported, 8 suggesting that CD28 hi may be a phenotypic marker of functional significance. This was confirmed by depleting CD28
hi from the CD8 + T cells of 7-day injured WT mice, which resulted in reduced cytolytic activity against syngeneic SMCs. The signaling that occurs through CD28 during T-cell activation is downregulated by CTLA-4. Interestingly, in our study, even as there was increased cytolytic activity by CD8 + T cells from CD4À/À mice, there was also concomitantly increased CTLA-4 mRNA expression. In addition, lytic activity occurred with a compensatory increase in CTLA-4 expression in the CD8 + CD28 hi T cells. The results suggest that even as the CD28 hi subpopulation has increased activity, there remains a measure of self-control against an overly aggressive response against syngeneic cells.
The role of CD28 in the cytolytic activity by CD8 + T cells has been previously reported. 10 Of particular interest is the finding that increased B7-1 expression induced susceptibility nonresticted. It remains unknown if the lytic activity against syngeneic SMCs is MHC-I restricted, and our previous report suggests that it may not be. 8 In addition, attempts to block lytic activity using antibody against perforin in our study were unsuccessful (not shown), suggesting that the lytic activity is not mediated by perforin. The implications of our findings combined with other reports are apparent in the potential for autoimmune complications in the vascular wall. It is not unreasonable to speculate that autoimmune-mediated vasculitis may involve, among other causes, the convergence of changes in the vascular wall and in specific T-cell subtypes that may not necessarily have antigen specificity. In addition, it remains unknown what role, if any, cytolytic CD8 + CD28 hi T cells may play in arteries that have established atherosclerotic plaques with SMC-rich fibrous caps. CD8 + T-cell activation precedes CD4 + T-cell activation induced by feeding apoEÀ/À mice with an atherogenic diet. 26 Within the CD8 + T-cell population reported in the study, the CD28 + subtype had increased activation, 26 emphasizing the relevance of our results. In addition, our group recently reported the role of CD8 + T cells in an apoB-100-derived peptide vaccine that reduced atherosclerosis in apoEÀ/À mice. 27 Combined with these reports, our study underscores the work ahead to further reveal and better understand the interaction between CD8 + T cells and vascular cells.
The limitations of the study include the use of the CD4À/À mice, which have been reported to have compensatory changes. 28 However, functions attributed to CD8 + T cells from the CD4À/À mice were also present in the WT CD8 + T cells after arterial injury. The specific difference was that the Figure 6 . phenotype and functions of CD8 + T cells were exaggerated in the CD4À/À mice, with significantly reduced neointima formation, making it advantageous for our study.
In conclusion, our results provide additional evidence that CD8 + T cells are involved in controlling neointima formation after arterial injury. We identified CD8 + CD28 hi T cells as the specific subtype involved. These cells have cytolytic activity against syngeneic SMCs that express the costimulatory molecule B7-1. This study adds to the growing body of evidence that supports immune regulation of the remodeling of the vascular wall.
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